reports
- GlobalData Healthcare Department
Compugen Ltd (CGEN) - Financial Analysis Review
Compugen Ltd (CGEN) - Financial Analysis Review Summary Compugen Ltd (Compugen) is a drug discovery company that develops medicines for immuno-oncology and autoimmune diseases. The company’s immuno-oncology pipeline comprises CGEN-15001T, CGEN-15022, CGEN-15022, CGEN-15029, target candidates, immuno-modulatory target candidates and ADC target candidates. Its drug development process include target discovery, target validation and predictive discovery programs. The company also offers targets...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.